Jun 26, 2023
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $48.03 to $40.02.
The split itself did not change the total investment value.
Zhejiang Orient Gene Biotech Co., Ltd. Class A (SSE:688298) operates in the Medical specialties industry.
Zhejiang Orient Gene Biotech Co., Ltd. Class A company overviewZhejiang Orient Gene Biotech Co., Ltd. Class A's most recent stock split was on June 26, 2023. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Zhejiang Orient Gene Biotech Co., Ltd. Class A (SSE:688298) has split its stock 2 times: a 7-for-5 split on June 16, 2022 and a 6-for-5 split on June 26, 2023.
Zhejiang Orient Gene Biotech Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between June 16, 2022 and June 26, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Orient Gene Biotech Co., Ltd. Class A's 6-for-5 split on June 26, 2023, every 5 shares became 6 shares.
Zhejiang Orient Gene Biotech Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 26, 2023, 3 years ago. Companies announce splits in advance, and any new SSE:688298 split will appear on this page.
Already premium?